Dr. Hokanson is a psychiatrist that works with adolescents, young adults, women, and people of color who would benefit from a holistic mental health healing approach. She also conducts research in psychedelic-assisted psychotherapy and ketamine-assisted psychotherapy for obsessive-compulsive disorder, depression, and post-traumatic stress disorder. Dr. Hokanson completed her medical training at UT Southwestern medical school and psychiatric training at Yale University where she was the Chief Psychiatry Resident. She has completed additional training in integrative psychiatry as well as MDMA-assisted psychotherapy training for the treatment of PTSD. She is a study physician and co-therapist on several clinical trials for psilocybin-assisted psychotherapy for the obsessive-compulsive disorder and major depression disorder as well as Ketamine combined with prolonged exposure therapy for post-traumatic stress disorder. Dr. Hokanson's clinical interests include: Adolescent and young adult mental health, women’s mental health, depressive disorders, anxiety disorders, trauma-related disorders, psychedelic-assisted psychotherapy, ketamine-assisted psychotherapy, psychodynamic, and mindfulness-based therapy, and integrative psychiatry.

Science, Medicine, and Psychedelics

Emerging indications for psychedelic therapies

In the last fifteen years, psychedelics have been primarily investigated for treatment of depression, anxiety, and PTSD. More recently, research programs are exploring psychedelic therapies for other psychological and neurological disorders and illnesses, including obsessive compulsive disorder, Alzheimer’s disease, Lyme disease, adjustment disorder, and eating disorders. Join us to learn more about the new frontiers of clinical applications for psychedelics.